DO
SUPN icon

denkapparat Operations’s Supernus Pharmaceuticals SUPN Stock Holding History

denkapparat Operations’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Hold
6,202
– – 0.13% 264
2025
Q4 		$308K Hold
6,202
– – 0.17% 235
2025
Q3 		$296K Buy
+6,202
New +$250K 0.19% 206
2025
Q2 		– Sell
-6,202
Closed -$203K – 268
2025
Q1 		$203K Buy
+6,202
New +$220K 0.22% 205

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

denkapparat Operations's SUPN Position: Q1 2026 in Review

denkapparat Operations held its Supernus Pharmaceuticals (SUPN) position steady in Q1 2026 at 6,202 shares worth $321K. The position accounts for 0.13% of the portfolio, ranked #264.

denkapparat Operations first reported a position in SUPN in Q1 2025 and has held it in 4 quarters since. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • denkapparat Operations held 6,202 shares of Supernus Pharmaceuticals worth $321K as of Q1 2026.
  • denkapparat Operations left its Supernus Pharmaceuticals share count unchanged in Q1 2026.
  • Supernus Pharmaceuticals made up 0.13% of denkapparat Operations's portfolio in Q1 2026, its #264 holding.
  • denkapparat Operations first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on denkapparat Operations's 13F filing for Q1 2026, filed 11 May 2026.